» Articles » PMID: 36909112

Patients and Families' Participation in Multidisciplinary Tumor Conferences Improves Patient and Family-Focused Cancer Care: Lessons Learned From a Debate on the Role of Radiation Therapy in Primary Mediastinal Non-Hodgkin Lymphoma

Overview
Journal Cureus
Date 2023 Mar 13
PMID 36909112
Authors
Affiliations
Soon will be listed here.
Abstract

Incorporation of patients' preferences often leads to improved outcomes when included in the multidisciplinary tumor conference/board (MTC). However, patients' wishes are not included or considered in the MTC decision-making. We need better strategies and approaches for patient-inclusive, shared decision-making. When finding ourselves at a crossroads regarding the next step in a patient's treatment, we saw a unique opportunity for an MTC with the patient and her husband in attendance. The results of a full literature review regarding the role of consolidative radiation therapy (RT) in a patient with primary (thymic) B-cell lymphoma after completion of chemotherapy and fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT) scan with a Deauville score of 4 were presented in a creative, engaging debate-style forum with visual aids. The patient and her husband were able to follow the discussion and, in the end, a consensus recommendation, heavily focused on the patient's preferences, was offered and adopted, which ultimately resulted in the avoidance of excess treatment and likely improved her long-term quality of life outcome. These collaborative and innovative interactions benefit not only our patients but enrich our lives too as healthcare providers and strengthen us as a cancer care team in terms of understanding diversity in decision-making processes.

Citing Articles

Precision Population Cancer Medicine in Brain Tumors: A Potential Roadmap to Improve Outcomes and Strategize the Steps to Bring Interdisciplinary Interventions.

Velu U, Singh A, Nittala R, Yang J, Vijayakumar S, Cherukuri C Cureus. 2024; 16(10):e71305.

PMID: 39529768 PMC: 11552465. DOI: 10.7759/cureus.71305.


Novel Bispecific T-Cell Engagers for the Treatment of Relapsed B Cell Non-Hodgkin Lymphomas: Current Knowledge and Treatment Considerations.

Varon B, Horowitz N, Khatib H Patient Prefer Adherence. 2024; 18:2159-2167.

PMID: 39479221 PMC: 11523922. DOI: 10.2147/PPA.S485838.


Real World and Public Health Perspectives of Intraoperative Radiotherapy in Early-Stage Breast Cancer: A Multidisciplinary Analysis Beyond the Statistical Facts.

Vijayakumar S, Nittala M, Buddala V, Mobit P, Duggar W, Yang C Cureus. 2023; 15(3):e36432.

PMID: 37025715 PMC: 10072193. DOI: 10.7759/cureus.36432.

References
1.
Vijayakumar S, Lancaster F, Nittala M, Duggar W . The Emerging Boon of Information and Communication Technology in Multidisciplinary Cancer Care: A Force Multiplier With a Human Touch. Cureus. 2023; 15(1):e33665. PMC: 9917828. DOI: 10.7759/cureus.33665. View

2.
Stephens D, Li H, LeBlanc M, Puvvada S, Persky D, Friedberg J . Continued Risk of Relapse Independent of Treatment Modality in Limited-Stage Diffuse Large B-Cell Lymphoma: Final and Long-Term Analysis of Southwest Oncology Group Study S8736. J Clin Oncol. 2016; 34(25):2997-3004. PMC: 5012710. DOI: 10.1200/JCO.2015.65.4582. View

3.
Lee J, Oh D, Eom K, Kim J, Kim W, Chung M . The prognostic value of PET/CT evaluation with Deauville score on the recurrence and survival in diffuse large B-cell lymphoma: a multi-institutional study of KROG 17-02. Clin Exp Metastasis. 2019; 37(1):125-131. DOI: 10.1007/s10585-019-09992-z. View

4.
Ravdin P, Siminoff I, Harvey J . Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy. J Clin Oncol. 1998; 16(2):515-21. DOI: 10.1200/JCO.1998.16.2.515. View

5.
Lamb B, Taylor C, Lamb J, Strickland S, Vincent C, Green J . Facilitators and barriers to teamworking and patient centeredness in multidisciplinary cancer teams: findings of a national study. Ann Surg Oncol. 2012; 20(5):1408-16. DOI: 10.1245/s10434-012-2676-9. View